The Function and Significance of SELENBP1 Downregulation in Human Bronchial Epithelial Carcinogenic Process

Background Our quantitative proteomic study showed that selenium-binding protein 1 (SELENBP1) was progressively decreased in human bronchial epithelial carcinogenic process. However, there is little information on expression and function of SELENBP1 during human lung squamous cell cancer (LSCC) carcinogenesis. Methods iTRAQ-tagging combined with 2D LC-MS/MS analysis was used to identify differentially expressed proteins in the human bronchial epithelial carcinogenic process. SELENBP1, member of selenoproteins family and progressively downregulated in this process, was selected to further study. Both Western blotting and immunohistochemistry were performed to detect SELENBP1 expression in independent sets of tissues of bronchial epithelial carcinogenesis, and ability of SELENBP1 for discriminating NBE (normal bronchial epithelium) from preneoplastic lesions from invasive LSCC was evaluated. The effects of SELENBP1 downregulation on the susceptibility of benzo(a)pyrene (B[a]P)-induced human bronchial epithelial cell transformation were determined. Results 102 differentially expressed proteins were identified by quantitative proteomics, and SELENBP1 was found and confirmed being progressively decreased in the human bronchial epithelial carcinogenic process. The sensitivity and specificity of SELENBP1 were 80% and 79% in discriminating NBE from preneoplastic lesions, 79% and 82% in discriminating NBE from invasive LSCC, and 77% and 71% in discriminating preneoplastic lesions from invasive LSCC, respectively. Furthermore, knockdown of SELENBP1 in immortalized human bronchial epithelial cell line 16HBE cells significantly increased the efficiency of B[a]P-induced cell transformation. Conclusions The present data shows for the first time that decreased SELENBP1 is an early event in LSCC, increases B[a]P-induced human bronchial epithelial cell transformation, and might serve as a novel potential biomarker for early detection of LSCC.

[1]  D. Sze,et al.  Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial. , 2008, The Lancet. Oncology.

[2]  W. Rom,et al.  Preneoplastic lesions of the lung , 2002, Respiratory research.

[3]  J H Holbrook,et al.  The changing cigarette. , 1981, The Western journal of medicine.

[4]  R. Berkowitz,et al.  Selenium binding protein 1 in ovarian cancer , 2006, International journal of cancer.

[5]  G. Schrauzer.  Selenium and selenium-antagonistic elements in nutritional cancer prevention , 2009, Critical reviews in biotechnology.

[6]  I. Thompson,et al.  The Selenium and Vitamin E Cancer Prevention Trial , 2003, World Journal of Urology.

[7]  H M Rosenberg,et al.  Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. , 2001, Journal of the National Cancer Institute.

[8]  D. Parkin,et al.  Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.

[9]  M. Rayman.  Selenium in cancer prevention: a review of the evidence and mechanism of action , 2005, Proceedings of the Nutrition Society.

[10]  W. Cheng,et al.  Selenium Compounds Activate ATM-dependent DNA Damage Response via the Mismatch Repair Protein hMLH1 in Colorectal Cancer Cells* , 2010, The Journal of Biological Chemistry.

[11]  F. Bray,et al.  Estimation and projection of the national profile of cancer mortality in China: 1991–2005 , 2004, British Journal of Cancer.

[12]  A. Sytkowski,et al.  Human selenium binding protein-1 (hSP56) interacts with VDU1 in a selenium-dependent manner. , 2009, Biochemical and biophysical research communications.

[13]  A. Sytkowski,et al.  Differential expression and androgen regulation of the human selenium-binding protein gene hSP56 in prostate cancer cells. , 1998, Cancer research.

[14]  David E. Misek,et al.  Reduced selenium‐binding protein 1 expression is associated with poor outcome in lung adenocarcinomas , 2004, The Journal of pathology.

[15]  Zhuchu Chen,et al.  Identification of Novel Nasopharyngeal Carcinoma Biomarkers by Laser Capture Microdissection and Proteomic Analysis , 2008, Clinical Cancer Research.

[16]  J. Virtamo,et al.  Serum selenium and risk of cancer. A prospective follow‐up of nine years , 1987, Cancer.

[17]  D. Arango,et al.  Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. , 2008, Molecular nutrition & food research.

[18]  Martin L. Smith,et al.  Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex. , 2006, Anticancer research.

[19]  K. El-Bayoumy,et al.  The protective role of selenium on genetic damage and on cancer. , 2001, Mutation research.

[20]  Wancai Yang,et al.  Transcriptional Regulation and Biological Functions of Selenium-Binding Protein 1 in Colorectal Cancer In Vitro and in Nude Mouse Xenografts , 2009, PloS one.

[21]  A. Kyriakopoulos,et al.  Mammalian selenium-containing proteins. , 2003, Annual review of nutrition.

[22]  H. Osada,et al.  Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer , 2002, Oncogene.

[23]  A. Porat,et al.  A 56-kDa Selenium-binding Protein Participates in Intra-Golgi Protein Transport* , 2000, The Journal of Biological Chemistry.

[24]  Zhuchu Chen,et al.  Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. , 2010, Cancer research.

[25]  Y. Seo,et al.  Selenomethionine induction of DNA repair response in human fibroblasts , 2002, Oncogene.

[26]  Y. Shimosato,et al.  Histological Typing of Lung and Pleural Tumours , 1999, World Health Organization.

[27]  E. C. Hammond,et al.  Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs. 1970-1977. , 1979, The New England journal of medicine.

[28]  W. Cheng,et al.  Selenium Compounds Activate Early Barriers of Tumorigenesis* , 2010, The Journal of Biological Chemistry.

[29]  Jiao-Yang Li,et al.  Identification of Candidate Biomarkers for Early Detection of Human Lung Squamous Cell Cancer by Quantitative Proteomics* , 2012, Molecular & Cellular Proteomics.